NCT03571646

LIFEGUARD Study - Continuous Respiratory Monitoring on the General Ward

Name: Clinical Trial NCT03571646
Creator: Medtronic - MITG
Keywords: Respiratory Complication, Capnostream 20 monitoring, behavioral, clinical trial, Germany

Medtronic - MITG·ClinicalTrials.gov·behavioralTerminated

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Respiratory Complication
Drug/Device/Intervention: Capnostream 20 monitoring
Study type: Interventional
Intervention type: behavioral

Sponsor & location

Primary sponsor: Medtronic - MITG
Location: Bonn,Marburg, Germany

Timeline & enrollment

Phase: N/A
Start date: May 09, 2019
End date: Dec 14, 2019
Enrollment: 6 participants

Primary outcome

Quantify the Incidence and Severity of Post-operative Respiratory Compromise Markers

Summary

The purpose of this study is to document how often and how severe are the breathing difficulties that patients suffer, while recovering on a general ward following a serious operation

ICD-10 classifications

Respiratory disorder, unspecifiedOther respiratory disordersRespiratory failure, unspecifiedOther postprocedural respiratory disordersOther specified respiratory disorders

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT03571646
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT03571646 through Pure Global AI's free database. This phase not specified trial is sponsored by Medtronic - MITG and is currently Terminated. The study focuses on Respiratory Complication. Target enrollment is 6 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.